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Abstract 
Prader-Willi syndrome (PWS) is a rare condition due to deletion (del PWS) of 
paternal chromosomal material, or a maternal uniparental disomy (mUPD PWS), at 
15q11-13. Affective psychosis is more prevalent in mUPD PWS. We investigate the 
relationship between the two PWS genetic variants and brainstem serotonin (5-HTT) 
transporter availability in adult humans. Mean brainstem 5-HTT availability 
determined by [123I]-beta-CIT SPECT was lower in 8 adults with mUPD PWS 
compared to 9 adults with del PWS (mean difference = -0.93; t=-2.85; p=0.014). Our 
findings confirm an association between PWS genotype and brainstem 5-HTT 
availability, implicating a maternally expressed/paternally imprinted gene, that is 
likely to account for the difference in psychiatric phenotypes between the PWS 
variants.  
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Prader-Willi syndrome (PWS) is a rare genetic disorder, with a UK population 
prevalence of ~1 in 52,000(1). PWS is caused by lack of paternal contribution to the 
critical chromosome region at 15q11-13, due to deletion on the paternally inherited 
chromosome (del PWS - 70%) or maternal uniparental disomy (mUPD PWS - 25%). 
Imprinted genes are monoallelically expressed in a parent-of-origin dependent 
manner. PWS is associated with a distinct physical phenotype including short 
stature, small hands and feet, hypogonadism and a characteristic facial appearance; 
and a behavioural phenotype characterised by increased appetite, mood swings, 
stubbornness, temper tantrums, aggression, repetitive speech(2). PWS is also 
associated with high rates of psychopathology, including affective disorders. Those 
with mUPD are considered at greater risk of developing an 'affective psychosis' 
compared to del PWS. The neurological pathophysiology underlying this 
phenomenon  is far from clear(3, 4). 
The serotonergic system is a prime candidate for explaining the high rates of 
affective disorders, and particularly affective psychosis in mUPD PWS.  It is well 
established that serotonin plays a crucial role in brain development, and emotional 
regulation,  and has been implicated in the development of affective disorders like 
major depression (MDD)(5). Through examining the role of imprinted genes in brain 
serotonin neurochemistry, it may be possible to shed light on the neurobiological 
basis of higher rates of affective psychosis in those with mUPD PWS.  Previous 
research has shown greater serotonergic turnover, including increased monoamine 
oxidase activity in platelets and increased 5HIAA (breakdown product of serotonin) in 
the CSF of patients with PWS(6, 7). The aim of this project was to explore if 
serotonin transporter (5-HTT) availability differed significantly between the PWS 
variants. In keeping with the extant literature on serotonin turnover in PWS and 5-
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HTT availability in MDD, we hypothesized that mUPD PWS will have greater 
depressive symptoms and lower 5-HTT availability compared to del PWS(8) . 
Methods 
This was a UK-wide, cross-sectional study, comparing 5-HTT availability in 8 adults 
with mUPD PWS and 10 with del PWS, approved by the West of Scotland Research 
ethics committee and the Administration of Radioactive Substances Advisory 
Committee. None of the participants were being prescribed medications that interact 
with 5-HTT uptake. Depressive symptomatology was assessed using the Glasgow 
depression scale(9). Past psychotic episodes were recorded. All participants 
underwent [123I]-beta-CIT SPECT imaging using a previously validated protocol(10). 
Brain SPECT imaging was performed with a dedicated, 12 headed Neurofocus 900 
scanner (spatial resolution 7mm full width at half maximum; Neurophysics, 
Massachusetts), which acquires sequential single transaxial brain sections.  Subjects 
pretreated with 120mg of potassium iodide were scanned 3 – 4 hours after 
intravenous administration of [123I]-beta-CIT in order to establish uptake in 5-HTT rich 
areas(11).  Region of interest (ROI) analysis was carried out by an investigator (AN) 
blinded to the subject’s clinical and demographic history(10).  The ROI template 
consisted of manually drawn regions representing the brain stem (specific binding), 
and a reference ROI consisting of the occipital lobe (non-specific/non-displaceable 
binding) bilaterally.  The 5-HTT BPND (ratio at equilibrium of specifically bound 
radioligand to that of non-displaceable radioligand in tissue) was compared between 
the two groups using a general linear model, with brainstem ROI [123I]-beta-CIT 
uptake as dependent variable, and group (mUPD PWS vs. del PWS) as the 
categorical predictor variable, and occipital [123I]-beta-CIT uptake, age and sex as 
covariates. 
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Results 
We scanned 8 participants with mUPD and 10 participants with del PWS. The 
SPECT scan from one of the del PWS participants did not pass quality control and 
was discarded. Demographic and clinical details are shown in table 1. The mUPD 
group had greater GDS scores (non-significant) and had more past episodes of 
psychosis (non-significant) compared to the del group. On the general linear model, 
PWS variant was a significant predictor of 5HTBPND (F(1,12)=8.15;p=0.014).  The 
mUPD PWS group had significantly lower  5HTBPND compared to the del PWS 
group (mean difference = -0.93; t=-2.85; p=0.014; d= 2.35; 95%CI = 1.12 - 3.59) 
(figure 1).  
 
Discussion 
This is the first study to explore brainstem 5-HTT availability in PWS (12). Our 
findings reveal an association between PWS genotype and brainstem 5-HTT 
availability. The mUPD group had lower brainstem 5-HTT availability compared to 
the del group. MDD  has previously been associated with low 5-HTT availability due 
to the compensatory down-regulation of 5-HTT secondary to low synaptic serotonin 
concentrations(8). In keeping with this, we postulate that those with mUPD have a 
lower synaptic serotonin concentration compared to those with del PWS, and that 
this may indeed account for the greater prevalence of affective psychotic illness in 
this population(8). Greater serotonin turnover (greater plasma MAO-B and CSF 
HIAA) has been previously demonstrated in patients with PWS, compared to healthy 
controls(6, 7). In addition, treatment with SSRIs have been found to be effective in 
tackling affective and behavioural problems in individuals with PWS. Together with 
the above findings, our results, suggest that those with mUPD PWS have lower 
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synaptic serotonin concentrations compared to del PWS - a finding that has not been 
previously demonstrated.  Although Akefeldt et al found evidence for lower synaptic 
serotonin in PWS as a group, compared to healthy controls, they did not test if this 
finding was driven primarily by the mUPD variants within the group. The lack of a 
control group in our study prevented us from exploring if 5HTT availability was 
indeed lower in the del PWS group compared to healthy controls. Future studies will 
be required to explore the relationship between serotonin availability and turnover in 
PWS variants in relation to healthy population. 
Children with mUPD PWS have been found to have smaller cortical and subcortical 
grey matter volumes compared to neurotypical children(13, 14). In this context,  
lower 5HTT availability may also be due to smaller volume of serotonergic neurons 
in the brainstem.  However, Honea et al found no difference in brainstem volumes 
between the two genotypes, suggesting that  the lower 5TT availability is unlikely to 
be the result of smaller volume of brainstem serotonergic neurons(15). Nevertheless,  
serotonin influences neurogenesis, cell migration, synaptic plasticity, dendritic growth 
and normal spine formation and our findings could therefore be the result of a 
combination of the above(16).  
Our study has strengths and limitations. It was a UK-wide study with the support  
from the UK PWS Association. Despite the small sample sizes, at the end of study 
recruitment, the pool of eligible adults with mUPD PWS who fulfilled the inclusion 
criteria was exhausted. The 12-detector dedicated head SPECT unit ensured high 
spatial resolution; and, although more selective ligands for 5-HTT are available, the 
uptake of [123I]-beta-CIT in the brainstem at 4 hours is a validated measure of 5-HTT 
availability(11) . Lack of a neurotypical comparison group prevented us from 
comparing our findings to the healthy population. A cross sectional design and the 
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relatively small sample size precluded a mediation analysis to ascertain causal 
relationship between 5-HTT availability differences and affective psychosis. 
 
In summary, we have shown that a group of adults with mUPD PWS have lower 5-
HTT availability compared to the del PWS group. Our findings provide preliminary 
evidence for the pathophysiology underlying greater affective psychopathology 
associated with the mUPD group of patients, and the potential reasons why drugs 
like SSRIs are effective in treating this cohort of patients.   
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Table1. Demographic and clinical variables in the two patient groups. 
 mUPD PWS (8) Del PWS (9) Statistic p(two tailed) 
Mean age in 
years (s.d.) 
31.25 (9.09) 29.78 (7.13) t=0.37 0.72 
Sex (female-n) 6 (75%) 6 (66.7%) 2=0.14 0.71 
Mean GDS 
score (s.d.) 
6.75 (5.11) 4.55 (2.65) t=1.09 0.3 
Past history 
of psychosis 
(n) 
5 (62.5%) 3 (33.5%) 2=1.45 0.23 
 
GDS = Glasgow depression scale for people with a learning disability; mUPD =  
maternal uniparental disomy Prader-Willi syndrome;  Del PWS = deletion Prader-
Willi syndrome.  
 
